Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Medicare Part B
Payers
Feds flag 48 drugs subject to rebates under IRA powers
CMS announced a list of 48 Part B drugs with prices that rose faster than the rate of inflation in 2023 Q3. Here's what they plan to do now.
Noah Tong
Dec 14, 2023 1:00pm
Another round of Part B drugs capped by inflation rebates
Sep 14, 2023 4:55pm
CMS Innovation Center, HHS release new dementia care model
Jul 31, 2023 10:31am
HHS unveils 2nd wave of inflation-capped Part B drugs
Jun 9, 2023 11:07am
Pharmas preparing legal challenge to CMS' drug price negotiation
May 9, 2023 11:00am
HHS quietly trims list of price capped Medicare drugs down to 20
Apr 7, 2023 10:30am